Alfred D. Kingsley - 23 Jun 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Reporting relationship: Director
Issuer ticker: OCX
Reported as of: 23 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jun 2023, 21:30:12 UTC
Prior SEC filing: 15 Jun 2023
Next SEC filing: 03 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ Alfred D. Kingsley

Key filing fact

Alfred D. Kingsley filed Form 4 for Oncocyte Corp (OCX) on 27 Jun 2023.

Key facts

This page summarizes Alfred D. Kingsley's Form 4 filing for Oncocyte Corp (OCX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 Jun 2023, 21:30.

Change

Previous filing in this sequence was filed on 15 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OCX transaction

Common Stock, no par value

Award

Transaction value: $0
Shares: +20,000
Change %: +4.3%
Price: $0.000000
Shares after: 489,111
Date: 23 Jun 2023
Ownership: Direct
Footnotes: F1

OCX holding

Common Stock, no par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 75,345
Date: 23 Jun 2023
Ownership: See Footnote
Footnotes: F2

OCX holding

Common Stock, no par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 18,767
Date: 23 Jun 2023
Ownership: See Footnote
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OCX transaction Derivative

Option to Purchase Common Stock

Award

Transaction value: $0
Shares: +90,000
Change %
Price: $0.000000
Shares after: 90,000
Date: 23 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.2000
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.

Footnote F2

The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.

Footnote F3

The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.

Footnote F4

Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.